The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs

Tencho Tenev1, Katiuscia Bianchi, Maurice Darding

  • 1The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK. tencho.tenev@icr.ac.uk

Molecular Cell
|July 9, 2011
PubMed

Insights

Scientists discovered the Ripoptosome, a large cell death platform crucial for anticancer drug efficacy. This complex forms under genotoxic stress, independent of known death pathways, and promotes cancer cell death.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Drug Discovery

Background:

  • Understanding anticancer drug mechanisms is vital for improving combination therapies.
  • Genotoxic stress is a key mechanism by which chemotherapeutics induce cancer cell death.
  • The precise molecular platforms mediating stress-induced cell death remain incompletely defined.

Purpose of the Study:

  • To identify and characterize novel cell death platforms involved in anticancer drug action.
  • To elucidate the molecular composition and assembly requirements of the Ripoptosome.
  • To investigate the role of the Ripoptosome in mediating cancer cell death upon genotoxic stress.

Main Methods:

  • Cellular assays to detect and analyze large protein complexes.
  • Biochemical analyses including immunoprecipitation and Western blotting.
  • Studies involving genotoxic agents (e.g., etoposide) and Smac-mimetics.

Main Results:

  • Discovery of a ~2MDa cell death-inducing platform, the Ripoptosome, containing RIP1, FADD, and caspase-8.
  • Ripoptosome assembly is triggered by genotoxic stress-induced depletion of IAPs (XIAP, cIAP1, cIAP2).
  • Formation occurs independently of TNF, death receptors, and mitochondrial pathways, and requires RIP1 kinase activity.
  • The Ripoptosome mediates both apoptosis and necrosis and is negatively regulated by FLIP and IAPs.
  • Etoposide-induced Ripoptosome formation converts inflammatory signals into pro-death signals.

Conclusions:

  • The Ripoptosome represents a novel, fundamental cell death platform assembled under genotoxic stress.
  • Its assembly and function provide new insights into how chemotherapeutics kill cancer cells.
  • Targeting the Ripoptosome or its regulators could offer new strategies for cancer therapy.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...